Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Lanvers

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
The Journal of Pathology|September 19, 2002
Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTRChristopher Poremba, Bernhard Heine, Raihanatou Diallo, et al.
Blood|January 23, 2014
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemiaWing H Tong, Rob Pieters, Gertjan J L Kaspers, et al.
Blood|July 18, 2024
Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB::NOTCH1 fusions with unfavorable outcomeMarcel Te Vrugt, Janna Wessolowski, Gerrit Randau, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2008
Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapyKarl-Ludwig Schaefer, Martin Eisenacher, Yvonne Braun, et al.
European Journal of Human Genetics : EJHG|June 18, 2021
A comparison of genotyping arraysJoost A M Verlouw, Eva Clemens, Jard H de Vries, et al.
Haematologica|February 2, 2019
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 studyCarmelo Rizzari, Claudia Lanvers-Kaminsky, Maria Grazia Valsecchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2023
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized StudyValentino Conter, Maria Grazia Valsecchi, Gunnar Cario, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
The Journal of Pathology|September 19, 2002
Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTRChristopher Poremba, Bernhard Heine, Raihanatou Diallo, et al.
Blood|January 23, 2014
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemiaWing H Tong, Rob Pieters, Gertjan J L Kaspers, et al.
Blood|July 18, 2024
Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB::NOTCH1 fusions with unfavorable outcomeMarcel Te Vrugt, Janna Wessolowski, Gerrit Randau, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2008
Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapyKarl-Ludwig Schaefer, Martin Eisenacher, Yvonne Braun, et al.
European Journal of Human Genetics : EJHG|June 18, 2021
A comparison of genotyping arraysJoost A M Verlouw, Eva Clemens, Jard H de Vries, et al.
Haematologica|February 2, 2019
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 studyCarmelo Rizzari, Claudia Lanvers-Kaminsky, Maria Grazia Valsecchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2023
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized StudyValentino Conter, Maria Grazia Valsecchi, Gunnar Cario, et al.
Pageof 6